US-based Novavax and the Canadian government have reached an agreement to supply the country with up to 76 million doses of a possible vaccine for COVID-19.
Prime Minister Justin Trudeau made the announcement this morning in Montreal.
Novavax’s vaccine is in preliminary trials in the US and Australia and needs to pass safety reviews then be approved by Health Canada.
The vaccine is in its second phase of clinical trials and is set to enter the third phase in September.
The 76 million doses of the vaccine in the contract would almost be enough to give every Canadian 2 doses.
This is the third deal that the Canadian government has made with COVID-19 vaccine developers.
